Tag: <span>Mesothelioma News</span>

Asbestos Ban in US Inches Closer with New Legislation

Federal lawmakers this week passed one of the most important environmental bills that will overhaul how the U.S. government regulates toxic chemicals, and it could bring the nation closer to banning asbestos. The U.S. Senate passed the Frank R. Lautenberg Chemical Safety for the 21st Century Act, which amends the Toxic Substances Control Act (TSCA)…

The post Asbestos Ban in US Inches Closer with New Legislation appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Aid-in-dying law concerns some Latinos, blacks

Youssef Cohen, 68, sits while undergoing cancer treatment as his wife Lindsay Wright looks on, on March 17, 2016 in New York City. Cohen has an incurable cancer called mesothelioma and is advocating for the right to choose how and when he will die, proposed in New York State’s End of Life Options Act, currently in front of the state legislature.

New Law Could Ban Asbestos in United States

There have been some exciting new developments with regards to the country’s Chemical Safety Regulations. Asbestos, the known carcinogen once used as a flame retardant and in insulation could possibly be banned in the United States, under new laws and regulations from Congress.  While The Chemical Safety regulations that have been implemented in this country

more

Don’t Get Sandbagged – OSHA Releases Final Silica Rule

Seyfarth Synopsis: OSHA’s new Silica Rule will have a lasting effect on nearly 2.3 million workers and over 675,000 employers. The chances are high that the new Silica Rule will affect your business and may require you to implement new policies and programs to protect your employees’ safety.

ASCO2016: SELLAS Life Sciences Group Announces Exciting Results For…

ASCO 2016: SELLAS Life Sciences Group Announces Exciting Results For Galinpepimut-S, The Company’s WT1 Vaccine, In Patients With Acute Myeloid Leukemia And Malignant Pleural Mesothelioma , As Presented At The 2016 ASCO Annual Meeting /PRNewswire/ — SELLAS Life Sciences Group , a development-stage biopharmaceutical company with its main focus on developing innovative products to treat cancer, today announced that promising results from a Phase 2 trial of galinpepimut-S, the Company’s WT1 cancer vaccine, in patients with acute myeloid leukemia were presented in an oral presentation at the Annual Meeting of the American Society of Clinical Oncology , being held in .

Jury awards $8.75 million in asbestos lawsuit

A jury has awarded $8.75 million to a 65-year-old man who has incurable cancer as a result of asbestos exposure in the 1970s. The Oregonian/OregonLive reports that David Hoff’s attorneys say the former construction worker’s mesothelioma was caused by a wallboard product that became airborne when it was sanded down.